Akums Drugs and Pharmaceuticals has reported its audited financial results for the quarter and year ended March 31, 2026. The Board of Directors has recommended a total dividend of ₹3.00 per equity share, comprising a ₹1.00 final dividend and a ₹2.00 special dividend. The announcement follows a year of strategic growth, internal restructuring, and the advancement of its ongoing expansion initiatives, with the 22nd Annual General Meeting scheduled for July 10, 2026.
Financial Highlights for FY26
For the financial year ended March 31, 2026, the company achieved a standalone revenue from operations of ₹13,487.36 million, with a net profit for the year of ₹1,116.40 million. On a consolidated basis, the group performance was strong, delivering an annual revenue of ₹43,590.17 million and a net profit of ₹2,563.97 million. Earnings per share (EPS) for the consolidated entity stood at ₹16.67 for the full year.
Dividend Recommendations
Reflecting confidence in the company’s financial position and commitment to rewarding shareholders, the Board has recommended a final dividend of ₹1.00 (@ 50%) and a special dividend of ₹2.00 (@ 100%) per equity share of face value ₹2. The record date for determining the eligibility of shareholders for these payments has been fixed as Friday, July 3, 2026.
Operational and Management Updates
The company continues to advance its strategic priorities, including capital allocation for organic and inorganic growth. Following the annual review of governance, the Board announced leadership changes in the senior management team, including the appointment of Mr. V Jagannathan as President – HR, effective May 14, 2026, and the cessation of Mr. Arvind Srivastava from the same position.
Annual General Meeting
The company has scheduled its 22nd Annual General Meeting (AGM) to be held on Friday, July 10, 2026, at 11:00 AM IST. The meeting will be conducted through video conferencing and other audio-visual means, with the formal notice and integrated annual report to be dispatched to shareholders in due course.
Source: BSE
